Please login to the form below

Not currently logged in
Email:
Password:

Evotec CEO Werner Lanthaler temporarily stands down

Cites health reasons

Evotec's CEO Dr Werner Lanthaler, has temporarily stood down from his role within the company due to health reasons.

Dr Lanthaler informed the supervisory board of his situation, and the board approved approved his leave of absence. It also wished Dr Lanthaler an early recovery.

The management board of Dr Cord Dohrmann and Colin Bond, under the direction of Dr Mario Polywka, the chief operating officer, will lead the company in the absence of Dr Lanthaler.

He will reassume the role of CEO as soon as he has recovered.

5th October 2012

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics